img

Global Polio Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Polio Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Polio vaccines are vaccines used to prevent poliomyelitis. There are two typesone that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2023.
The global Polio Vaccines market size was US$ 709.8 million in 2024 and is forecast to a readjusted size of US$ 835.1 million by 2034 with a CAGR of 2.3% during the forecast period 2024-2034.
Sanofi, GSK and Serum Institute are the top 3 players of Polio Vaccine with about 98% market shares.
In terms of sales (consumption) side, this report focuses on the sales of Polio Vaccines by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2034.
The global Polio Vaccines market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Polio Vaccines market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


CSL
GlaxoSmithKline
Johnson & Johnson
MedImmune
Merck
Pfizer
Sanofi Pasteur
Serum Institute
By Type
IPV
OPV
By Application
Age (0-1)
Age Above 1
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Polio Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Polio Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Polio Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Polio Vaccines Definition
1.2 Market by Type
1.2.1 Global Polio Vaccines Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 IPV
1.2.3 OPV
1.3 Market Segment by Application
1.3.1 Global Polio Vaccines Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Age (0-1)
1.3.3 Age Above 1
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Polio Vaccines Sales
2.1 Global Polio Vaccines Revenue Estimates and Forecasts 2018-2034
2.2 Global Polio Vaccines Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Polio Vaccines Revenue by Region
2.3.1 Global Polio Vaccines Revenue by Region (2018-2023)
2.3.2 Global Polio Vaccines Revenue by Region (2024-2034)
2.4 Global Polio Vaccines Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Polio Vaccines Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Polio Vaccines Sales Quantity by Region
2.6.1 Global Polio Vaccines Sales Quantity by Region (2018-2023)
2.6.2 Global Polio Vaccines Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Polio Vaccines Sales Quantity by Manufacturers
3.1.1 Global Polio Vaccines Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Polio Vaccines Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Polio Vaccines Sales in 2024
3.2 Global Polio Vaccines Revenue by Manufacturers
3.2.1 Global Polio Vaccines Revenue by Manufacturers (2018-2023)
3.2.2 Global Polio Vaccines Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Polio Vaccines Revenue in 2024
3.3 Global Polio Vaccines Sales Price by Manufacturers
3.4 Global Key Players of Polio Vaccines, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Polio Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Polio Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Polio Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Polio Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Polio Vaccines Sales Quantity by Type
4.1.1 Global Polio Vaccines Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Polio Vaccines Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Polio Vaccines Sales Quantity Market Share by Type (2018-2034)
4.2 Global Polio Vaccines Revenue by Type
4.2.1 Global Polio Vaccines Historical Revenue by Type (2018-2023)
4.2.2 Global Polio Vaccines Forecasted Revenue by Type (2024-2034)
4.2.3 Global Polio Vaccines Revenue Market Share by Type (2018-2034)
4.3 Global Polio Vaccines Price by Type
4.3.1 Global Polio Vaccines Price by Type (2018-2023)
4.3.2 Global Polio Vaccines Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Polio Vaccines Sales Quantity by Application
5.1.1 Global Polio Vaccines Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Polio Vaccines Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Polio Vaccines Sales Quantity Market Share by Application (2018-2034)
5.2 Global Polio Vaccines Revenue by Application
5.2.1 Global Polio Vaccines Historical Revenue by Application (2018-2023)
5.2.2 Global Polio Vaccines Forecasted Revenue by Application (2024-2034)
5.2.3 Global Polio Vaccines Revenue Market Share by Application (2018-2034)
5.3 Global Polio Vaccines Price by Application
5.3.1 Global Polio Vaccines Price by Application (2018-2023)
5.3.2 Global Polio Vaccines Price Forecast by Application (2024-2034)
6 North America
6.1 North America Polio Vaccines Sales by Company
6.1.1 North America Polio Vaccines Revenue by Company (2018-2023)
6.1.2 North America Polio Vaccines Sales Quantity by Company (2018-2023)
6.2 North America Polio Vaccines Market Size by Type
6.2.1 North America Polio Vaccines Sales Quantity by Type (2018-2034)
6.2.2 North America Polio Vaccines Revenue by Type (2018-2034)
6.3 North America Polio Vaccines Market Size by Application
6.3.1 North America Polio Vaccines Sales Quantity by Application (2018-2034)
6.3.2 North America Polio Vaccines Revenue by Application (2018-2034)
6.4 North America Polio Vaccines Market Size by Country
6.4.1 North America Polio Vaccines Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Polio Vaccines Revenue by Country (2018-2034)
6.4.3 North America Polio Vaccines Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Polio Vaccines Sales by Company
7.1.1 Europe Polio Vaccines Sales Quantity by Company (2018-2023)
7.1.2 Europe Polio Vaccines Revenue by Company (2018-2023)
7.2 Europe Polio Vaccines Market Size by Type
7.2.1 Europe Polio Vaccines Sales Quantity by Type (2018-2034)
7.2.2 Europe Polio Vaccines Revenue by Type (2018-2034)
7.3 Europe Polio Vaccines Market Size by Application
7.3.1 Europe Polio Vaccines Sales Quantity by Application (2018-2034)
7.3.2 Europe Polio Vaccines Revenue by Application (2018-2034)
7.4 Europe Polio Vaccines Market Size by Country
7.4.1 Europe Polio Vaccines Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Polio Vaccines Revenue by Country (2018-2034)
7.4.3 Europe Polio Vaccines Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Polio Vaccines Sales by Company
8.1.1 China Polio Vaccines Sales Quantity by Company (2018-2023)
8.1.2 China Polio Vaccines Revenue by Company (2018-2023)
8.2 China Polio Vaccines Market Size by Type
8.2.1 China Polio Vaccines Sales Quantity by Type (2018-2034)
8.2.2 China Polio Vaccines Revenue by Type (2018-2034)
8.3 China Polio Vaccines Market Size by Application
8.3.1 China Polio Vaccines Sales Quantity by Application (2018-2034)
8.3.2 China Polio Vaccines Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Polio Vaccines Sales by Company
9.1.1 APAC Polio Vaccines Sales Quantity by Company (2018-2023)
9.1.2 APAC Polio Vaccines Revenue by Company (2018-2023)
9.2 APAC Polio Vaccines Market Size by Type
9.2.1 APAC Polio Vaccines Sales Quantity by Type (2018-2034)
9.2.2 APAC Polio Vaccines Revenue by Type (2018-2034)
9.3 APAC Polio Vaccines Market Size by Application
9.3.1 APAC Polio Vaccines Sales Quantity by Application (2018-2034)
9.3.2 APAC Polio Vaccines Revenue by Application (2018-2034)
9.4 APAC Polio Vaccines Market Size by Region
9.4.1 APAC Polio Vaccines Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Polio Vaccines Revenue by Region (2018-2034)
9.4.3 APAC Polio Vaccines Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Polio Vaccines Sales by Company
10.1.1 Middle East, Africa and Latin America Polio Vaccines Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Polio Vaccines Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Polio Vaccines Market Size by Type
10.2.1 Middle East, Africa and Latin America Polio Vaccines Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Polio Vaccines Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Polio Vaccines Market Size by Application
10.3.1 Middle East, Africa and Latin America Polio Vaccines Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Polio Vaccines Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Polio Vaccines Market Size by Country
10.4.1 Middle East, Africa and Latin America Polio Vaccines Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Polio Vaccines Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Polio Vaccines Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 CSL
11.1.1 CSL Company Information
11.1.2 CSL Overview
11.1.3 CSL Polio Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 CSL Polio Vaccines Products and Services
11.1.5 CSL Polio Vaccines SWOT Analysis
11.1.6 CSL Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Information
11.2.2 GlaxoSmithKline Overview
11.2.3 GlaxoSmithKline Polio Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 GlaxoSmithKline Polio Vaccines Products and Services
11.2.5 GlaxoSmithKline Polio Vaccines SWOT Analysis
11.2.6 GlaxoSmithKline Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Overview
11.3.3 Johnson & Johnson Polio Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Johnson & Johnson Polio Vaccines Products and Services
11.3.5 Johnson & Johnson Polio Vaccines SWOT Analysis
11.3.6 Johnson & Johnson Recent Developments
11.4 MedImmune
11.4.1 MedImmune Company Information
11.4.2 MedImmune Overview
11.4.3 MedImmune Polio Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 MedImmune Polio Vaccines Products and Services
11.4.5 MedImmune Polio Vaccines SWOT Analysis
11.4.6 MedImmune Recent Developments
11.5 Merck
11.5.1 Merck Company Information
11.5.2 Merck Overview
11.5.3 Merck Polio Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Merck Polio Vaccines Products and Services
11.5.5 Merck Polio Vaccines SWOT Analysis
11.5.6 Merck Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Polio Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Pfizer Polio Vaccines Products and Services
11.6.5 Pfizer Polio Vaccines SWOT Analysis
11.6.6 Pfizer Recent Developments
11.7 Sanofi Pasteur
11.7.1 Sanofi Pasteur Company Information
11.7.2 Sanofi Pasteur Overview
11.7.3 Sanofi Pasteur Polio Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Sanofi Pasteur Polio Vaccines Products and Services
11.7.5 Sanofi Pasteur Polio Vaccines SWOT Analysis
11.7.6 Sanofi Pasteur Recent Developments
11.8 Serum Institute
11.8.1 Serum Institute Company Information
11.8.2 Serum Institute Overview
11.8.3 Serum Institute Polio Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Serum Institute Polio Vaccines Products and Services
11.8.5 Serum Institute Polio Vaccines SWOT Analysis
11.8.6 Serum Institute Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Polio Vaccines Value Chain Analysis
12.2 Polio Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Polio Vaccines Production Mode & Process
12.4 Polio Vaccines Sales and Marketing
12.4.1 Polio Vaccines Sales Channels
12.4.2 Polio Vaccines Distributors
12.5 Polio Vaccines Customers
13 Market Dynamics
13.1 Polio Vaccines Industry Trends
13.2 Polio Vaccines Market Drivers
13.3 Polio Vaccines Market Challenges
13.4 Polio Vaccines Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Polio Vaccines Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of IPV
Table 3. Major Manufacturers of OPV
Table 4. Global Polio Vaccines Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 5. Global Polio Vaccines Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Polio Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Polio Vaccines Revenue Market Share by Region (2018-2023)
Table 8. Global Polio Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Polio Vaccines Revenue Market Share by Region (2024-2034)
Table 10. Global Polio Vaccines Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Units)
Table 11. Global Polio Vaccines Sales by Region (2018-2023) & (K Units)
Table 12. Global Polio Vaccines Sales Market Share by Region (2018-2023)
Table 13. Global Polio Vaccines Sales by Region (2024-2034) & (K Units)
Table 14. Global Polio Vaccines Sales Market Share by Region (2024-2034)
Table 15. Global Polio Vaccines Sales Quantity by Manufacturers (2018-2023) & (K Units)
Table 16. Global Polio Vaccines Sales Quantity Share by Manufacturers (2018-2023)
Table 17. Global Polio Vaccines Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Polio Vaccines Revenue Share by Manufacturers (2018-2023)
Table 19. Global Polio Vaccines Price by Manufacturers 2018-2023 (USD/Unit)
Table 20. Global Key Players of Polio Vaccines, Industry Ranking, 2021 VS 2024
Table 21. Global Polio Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Polio Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polio Vaccines as of 2024)
Table 23. Global Key Manufacturers of Polio Vaccines, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Polio Vaccines, Product Offered and Application
Table 25. Global Key Manufacturers of Polio Vaccines, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Polio Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 28. Global Polio Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 29. Global Polio Vaccines Sales Quantity Share by Type (2018-2023)
Table 30. Global Polio Vaccines Sales Quantity Share by Type (2024-2034)
Table 31. Global Polio Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Polio Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Polio Vaccines Revenue Share by Type (2018-2023)
Table 34. Global Polio Vaccines Revenue Share by Type (2024-2034)
Table 35. Polio Vaccines Price by Type (2018-2023) & (USD/Unit)
Table 36. Global Polio Vaccines Price Forecast by Type (2024-2034) & (USD/Unit)
Table 37. Global Polio Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 38. Global Polio Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 39. Global Polio Vaccines Sales Quantity Share by Application (2018-2023)
Table 40. Global Polio Vaccines Sales Quantity Share by Application (2024-2034)
Table 41. Global Polio Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Polio Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Polio Vaccines Revenue Share by Application (2018-2023)
Table 44. Global Polio Vaccines Revenue Share by Application (2024-2034)
Table 45. Polio Vaccines Price by Application (2018-2023) & (USD/Unit)
Table 46. Global Polio Vaccines Price Forecast by Application (2024-2034) & (USD/Unit)
Table 47. North America Polio Vaccines Revenue by Company (2018-2023) & (US$ Million)
Table 48. North America Polio Vaccines Sales Quantity by Company (2018-2023) & (K Units)
Table 49. North America Polio Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 50. North America Polio Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 51. North America Polio Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 52. North America Polio Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Polio Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 54. North America Polio Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 55. North America Polio Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 56. North America Polio Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Polio Vaccines Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 58. North America Polio Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 59. North America Polio Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Polio Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 61. North America Polio Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 62. Europe Polio Vaccines Sales Quantity by Company (2018-2023) & (K Units)
Table 63. Europe Polio Vaccines Revenue by Company (2018-2023) & (US$ Million)
Table 64. Europe Polio Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 65. Europe Polio Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 66. Europe Polio Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 67. Europe Polio Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Polio Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 69. Europe Polio Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 70. Europe Polio Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 71. Europe Polio Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Polio Vaccines Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 73. Europe Polio Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 74. Europe Polio Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Polio Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 76. Europe Polio Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 77. China Polio Vaccines Sales Quantity by Company (2018-2023) & (K Units)
Table 78. China Polio Vaccines Revenue by Company (2018-2023) & (US$ Million)
Table 79. China Polio Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 80. China Polio Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 81. China Polio Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 82. China Polio Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Polio Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 84. China Polio Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 85. China Polio Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 86. China Polio Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Polio Vaccines Sales Quantity by Company (2018-2023) & (K Units)
Table 88. APAC Polio Vaccines Revenue by Company (2018-2023) & (US$ Million)
Table 89. APAC Polio Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 90. APAC Polio Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 91. APAC Polio Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 92. APAC Polio Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Polio Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 94. APAC Polio Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 95. APAC Polio Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 96. APAC Polio Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Polio Vaccines Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 98. APAC Polio Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 99. APAC Polio Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Polio Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 101. APAC Polio Vaccines Sales Quantity by Region (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America Polio Vaccines Sales Quantity by Company (2018-2023) & (K Units)
Table 103. Middle East, Africa and Latin America Polio Vaccines Revenue by Company (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Polio Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 105. Middle East, Africa and Latin America Polio Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 106. Middle East, Africa and Latin America Polio Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Polio Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Polio Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Middle East, Africa and Latin America Polio Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 110. Middle East, Africa and Latin America Polio Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 111. Middle East, Africa and Latin America Polio Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Polio Vaccines Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Polio Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Polio Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Polio Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 116. Middle East, Africa and Latin America Polio Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 117. CSL Company Information
Table 118. CSL Description and Overview
Table 119. CSL Polio Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 120. CSL Polio Vaccines Product and Services
Table 121. CSL Polio Vaccines SWOT Analysis
Table 122. CSL Recent Developments
Table 123. GlaxoSmithKline Company Information
Table 124. GlaxoSmithKline Description and Overview
Table 125. GlaxoSmithKline Polio Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 126. GlaxoSmithKline Polio Vaccines Product and Services
Table 127. GlaxoSmithKline Polio Vaccines SWOT Analysis
Table 128. GlaxoSmithKline Recent Developments
Table 129. Johnson & Johnson Company Information
Table 130. Johnson & Johnson Description and Overview
Table 131. Johnson & Johnson Polio Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 132. Johnson & Johnson Polio Vaccines Product and Services
Table 133. Johnson & Johnson Polio Vaccines SWOT Analysis
Table 134. Johnson & Johnson Recent Developments
Table 135. MedImmune Company Information
Table 136. MedImmune Description and Overview
Table 137. MedImmune Polio Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 138. MedImmune Polio Vaccines Product and Services
Table 139. MedImmune Polio Vaccines SWOT Analysis
Table 140. MedImmune Recent Developments
Table 141. Merck Company Information
Table 142. Merck Description and Overview
Table 143. Merck Polio Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 144. Merck Polio Vaccines Product and Services
Table 145. Merck Polio Vaccines SWOT Analysis
Table 146. Merck Recent Developments
Table 147. Pfizer Company Information
Table 148. Pfizer Description and Overview
Table 149. Pfizer Polio Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 150. Pfizer Polio Vaccines Product and Services
Table 151. Pfizer Polio Vaccines SWOT Analysis
Table 152. Pfizer Recent Developments
Table 153. Sanofi Pasteur Company Information
Table 154. Sanofi Pasteur Description and Overview
Table 155. Sanofi Pasteur Polio Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 156. Sanofi Pasteur Polio Vaccines Product and Services
Table 157. Sanofi Pasteur Polio Vaccines SWOT Analysis
Table 158. Sanofi Pasteur Recent Developments
Table 159. Serum Institute Company Information
Table 160. Serum Institute Description and Overview
Table 161. Serum Institute Polio Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 162. Serum Institute Polio Vaccines Product and Services
Table 163. Serum Institute Polio Vaccines SWOT Analysis
Table 164. Serum Institute Recent Developments
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Polio Vaccines Distributors List
Table 168. Polio Vaccines Customers List
Table 169. Polio Vaccines Market Trends
Table 170. Polio Vaccines Market Drivers
Table 171. Polio Vaccines Market Challenges
Table 172. Polio Vaccines Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Polio Vaccines Product Picture
Figure 2. Global Polio Vaccines Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Polio Vaccines Market Share by Type in 2024 & 2034
Figure 4. IPV Product Picture
Figure 5. OPV Product Picture
Figure 6. Global Polio Vaccines Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 7. Global Polio Vaccines Market Share by Application in 2024 & 2034
Figure 8. Age (0-1)
Figure 9. Age Above 1
Figure 10. Polio Vaccines Report Years Considered
Figure 11. Global Polio Vaccines Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Polio Vaccines Revenue 2018-2034 (US$ Million)
Figure 13. Global Polio Vaccines Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 14. Global Polio Vaccines Sales Quantity 2018-2034 (K Units)
Figure 15. Global Polio Vaccines Sales Quantity Market Share by Region (2018-2023)
Figure 16. Global Polio Vaccines Sales Quantity Market Share by Region (2024-2034)
Figure 17. North America Polio Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 18. North America Polio Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 19. Europe Polio Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 20. Europe Polio Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 21. China Polio Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 22. China Polio Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 23. APAC Polio Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 24. APAC Polio Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Polio Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. Middle East, Africa and Latin America Polio Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Polio Vaccines Sales Quantity in 2024
Figure 28. The Top 10 and Top 5 Players Market Share by Polio Vaccines Revenue in 2024
Figure 29. Polio Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 30. Global Polio Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 31. Global Polio Vaccines Revenue Market Share by Type (2018-2034)
Figure 32. Global Polio Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 33. Global Polio Vaccines Revenue Market Share by Application (2018-2034)
Figure 34. North America Polio Vaccines Revenue Market Share by Company in 2024
Figure 35. North America Polio Vaccines Sales Quantity Market Share by Company in 2024
Figure 36. North America Polio Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 37. North America Polio Vaccines Revenue Market Share by Type (2018-2034)
Figure 38. North America Polio Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 39. North America Polio Vaccines Revenue Market Share by Application (2018-2034)
Figure 40. North America Polio Vaccines Revenue Share by Country (2018-2034)
Figure 41. North America Polio Vaccines Sales Quantity Share by Country (2018-2034)
Figure 42. U.S. Polio Vaccines Revenue (2018-2034) & (US$ Million)
Figure 43. Canada Polio Vaccines Revenue (2018-2034) & (US$ Million)
Figure 44. Europe Polio Vaccines Sales Quantity Market Share by Company in 2024
Figure 45. Europe Polio Vaccines Revenue Market Share by Company in 2024
Figure 46. Europe Polio Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 47. Europe Polio Vaccines Revenue Market Share by Type (2018-2034)
Figure 48. Europe Polio Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 49. Europe Polio Vaccines Revenue Market Share by Application (2018-2034)
Figure 50. Europe Polio Vaccines Revenue Share by Country (2018-2034)
Figure 51. Europe Polio Vaccines Sales Quantity Share by Country (2018-2034)
Figure 52. Germany Polio Vaccines Revenue (2018-2034) & (US$ Million)
Figure 53. France Polio Vaccines Revenue (2018-2034) & (US$ Million)
Figure 54. U.K. Polio Vaccines Revenue (2018-2034) & (US$ Million)
Figure 55. Italy Polio Vaccines Revenue (2018-2034) & (US$ Million)
Figure 56. Russia Polio Vaccines Revenue (2018-2034) & (US$ Million)
Figure 57. China Polio Vaccines Sales Quantity Market Share by Company in 2024
Figure 58. China Polio Vaccines Revenue Market Share by Company in 2024
Figure 59. China Polio Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 60. China Polio Vaccines Revenue Market Share by Type (2018-2034)
Figure 61. China Polio Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 62. China Polio Vaccines Revenue Market Share by Application (2018-2034)
Figure 63. APAC Polio Vaccines Sales Quantity Market Share by Company in 2024
Figure 64. APAC Polio Vaccines Revenue Market Share by Company in 2024
Figure 65. APAC Polio Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 66. APAC Polio Vaccines Revenue Market Share by Type (2018-2034)
Figure 67. APAC Polio Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 68. APAC Polio Vaccines Revenue Market Share by Application (2018-2034)
Figure 69. APAC Polio Vaccines Revenue Share by Region (2018-2034)
Figure 70. APAC Polio Vaccines Sales Quantity Share by Region (2018-2034)
Figure 71. Japan Polio Vaccines Revenue (2018-2034) & (US$ Million)
Figure 72. South Korea Polio Vaccines Revenue (2018-2034) & (US$ Million)
Figure 73. China Taiwan Polio Vaccines Revenue (2018-2034) & (US$ Million)
Figure 74. Southeast Asia Polio Vaccines Revenue (2018-2034) & (US$ Million)
Figure 75. India Polio Vaccines Revenue (2018-2034) & (US$ Million)
Figure 76. Middle East, Africa and Latin America Polio Vaccines Sales Quantity Market Share by Company in 2024
Figure 77. Middle East, Africa and Latin America Polio Vaccines Revenue Market Share by Company in 2024
Figure 78. Middle East, Africa and Latin America Polio Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 79. Middle East, Africa and Latin America Polio Vaccines Revenue Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Polio Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 81. Middle East, Africa and Latin America Polio Vaccines Revenue Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Polio Vaccines Sales Quantity Share by Country (2018-2034)
Figure 83. Middle East, Africa and Latin America Polio Vaccines Revenue Share by Country (2018-2034)
Figure 84. Brazil Polio Vaccines Revenue (2018-2034) & (US$ Million)
Figure 85. Mexico Polio Vaccines Revenue (2018-2034) & (US$ Million)
Figure 86. Turkey Polio Vaccines Revenue (2018-2034) & (US$ Million)
Figure 87. Israel Polio Vaccines Revenue (2018-2034) & (US$ Million)
Figure 88. GCC Countries Polio Vaccines Revenue (2018-2034) & (US$ Million)
Figure 89. Polio Vaccines Value Chain
Figure 90. Polio Vaccines Production Process
Figure 91. Channels of Distribution (Direct Vs Distribution)
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries